Wei-Wei Lu (Weiwei Lu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cardiovascular Disease

Top Venues

American journal of cardiovascular drugs : drugs, devices, and other interventions

Oxidative medicine and cellular longevity

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Pengchen Gu, Yuxin Wu, Wei-Wei Lu
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (2) (2024)
Pengchen Gu, Yuxin Wu, Wei-Wei Lu
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases. American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
Pengchen Gu, Yuxin Wu, Wei-Wei Lu
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (2) (2024)
Pengchen Gu, Yuxin Wu, Wei-Wei Lu
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (2) (2024)
Yao Chen, Yong-Fen Qi, Wei-Wei Lu
Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases. Oxidative medicine and cellular longevity 2022 (2022)
Jin-Ling Ren, Yao Chen, Lin-Shuang Zhang, Ya-Rong Zhang, Shi-Meng Liu, Yan-Rong Yu, Mo-Zhi Jia, Chao-Shu Tang, Yong-Fen Qi, Wei-Wei Lu
Intermedin1-53 attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages. Cell death & disease 12 (5) (2021)